quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 21, 2026

Stock market today: Dow, S&P 500, Nasdaq jump as Trump says US, NATO have 'framework' of a deal for Greenland

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq jump as Trump says US, NATO have 'framework' of a deal for Greenland US stocks spiked on Wednesday following social media post from President Trump announcing the US and NATO "formed the framework of a future deal with respect to Greenland and, in fact, the entire Arctic Region"…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • In a bubble, the fear would be AI not growing fast enough or companies spending too much, but both concerns are not well founded

    80% confidence
  • Asking Congress to cap credit card interest rates at 10% for one year to help Americans save for homes

    80% confidence
  • Congress working on crypto market structure legislation which he hopes to sign soon

    80% confidence
  • Seeing a boom in trade jobs with six figure salaries helping to build AI infrastructure

    80% confidence
  • Positive market dynamics in data center server space but Intel manufacturing has quite a ways to go

    80% confidence
  • America will not become a nation of renters

    80% confidence
  • Greater demand for CPUs from data centers due to agentic AI

    80% confidence
  • Defense contractors will build additional plants with money from stock buybacks

    80% confidence
  • Beating consensus isn't the hurdle right now, need to raise forward path enough to justify rich valuations

    80% confidence
  • US and NATO formed the framework of a future deal with respect to Greenland and the entire Arctic Region

    80% confidence
  • Seeking immediate negotiations on US taking full ownership of Greenland

    80% confidence
  • AI companies' valuations decreased in 2025 while earnings grew over 30%

    80% confidence
  • Working to ensure America remains the crypto capital of the world

    80% confidence
  • 10% credit card interest rate cap would cause economic disaster and force banks to cancel credit lines for many Americans

    80% confidence
  • Confident in regulatory approval for Warner Bros. Discovery acquisition

    80% confidence
  • Will not impose tariffs scheduled for February 1st due to Greenland deal understanding

    80% confidence
  • Wouldn't use excessive strength and force to acquire Greenland

    80% confidence
  • AI is not in a bubble because real businesses are growing with earnings outpacing stock prices

    80% confidence
  • Credit card companies charge 28-32% interest rates and have profit margins exceeding 50%

    80% confidence
  • Continue to invest in mRNA platform in oncology due to encouraging outcomes showing potential in cancer care

    80% confidence
  • US makes the greatest weapons in the world and will make them faster

    80% confidence
  • Trillions of dollars of AI infrastructure needs to be built

    80% confidence
  • Strong signals for Intel's PC chips and improving outlook for manufacturing business

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com